期刊文献+

福建省福州地区幽门螺旋杆菌对常用抗菌药物的体外耐药情况及变化研究 被引量:1

Study on Resistance of Helicobacter pylori to Commonly Used Antibiotics in Vitro in Fuzhou,Fujian Province
下载PDF
导出
摘要 目的研究近15年来福州地区幽门螺旋杆菌(Helicobacter pylori,Hp)对常用抗菌药物体外耐药情况及变化。方法分别收集2004~2006年及2016~2019年在福建省立医院内镜中心行胃镜检查患者的胃黏膜标本,在微需氧环境下进行Hp分离培养,并进行菌株鉴定,分别采用琼脂稀释法和微量肉汤稀释法对3种抗菌药物(阿莫西林(AMX)、克拉霉素(CLA)和甲硝唑(MET)进行体外药敏试验。结果共获得了270株分离株,2004~2006年和2016~2019年Hp对MET耐药率分别为50.00%和73.68%,P值0.015;对CLA耐药率分别为27.56%和42.10%,P值0.013;对AMX耐药率分别为1.28%和20.18%,P值<0.0001,均有统计学意义。结论近15年来福建省福州地区Hp对MET、CLA及AMX耐药率均有增加,推荐该地区患者根除Hp之前进行药敏试验。 OBJECTIVE To study the resistance of Helicobacter pylori(Hp)to commonly used antibiotics in Fuzhou city over the past 15 years.METHODS Gastric mucosa specimens were collected from the patients between 2004 to 2006 and between 2016 to 2019 in endoscopy center of Fujian Province Hospital,and Hp were cultured under the microaerobic condition.After strain identification,drug susceptibility tests to three kinds of antibiotics(amoxicillin(AMX)and clarithromycin(CLA)and metronidazole(MET)were administered using agar dilution method and broth dilution method respectively in vitro.RESULTS A total of 270 isolates were obtained.The resistance rates of Hp in 2004-2006 and 2016-2019 to MTX were 50.00%(78/156)and 73.68%(74/114),respectively,with a P value of 0.015;to CLA were 27.56%(43/156)and 42.10%(48/114),respectively,with a P value of 0.013 and to AMX were 1.28%(2/156)and 20.18%(23/114),respectively,with P<0.0001,which were all statistically significant.CONCLUSION The drug resistance rates of Hp to MET,CLA and AMX have increased in the past 15 years in Fuzhou,Fujian province.Therefore,drug resistance tests for MET,CLA and AMX are recommended before the treatment of Hp eradication in this region.
作者 黄雪平 陆玉萍 王明霞 张玉容 林悦 林志辉 HUANG Xue-ping;LU Yu-ping;WANG Ming-xia;ZHANG Yu-rong;LIN Yue;LIN Zhi-hui(Department of Gastroenterology,Fujian Provincial Hospital,Fuzhou 310001,China;Fujian Institute of gastroenterology,Fuzhou 310001,China;Shengli Clinical Medical College of Fujian Medical University,Fuzhou 310004,China)
出处 《海峡药学》 2021年第10期75-78,共4页 Strait Pharmaceutical Journal
基金 福建省自然面上基金项目(2020J011087) 福建省卫生计生青年科研课题(2016-1-5) 福建省立医院院内重点课题(2014YNZD04)。
关键词 幽门螺旋杆菌 抗菌药物 耐药 福州 Helicobacter pylori Antibiotics Drug resistance Fuzhou
  • 相关文献

参考文献1

二级参考文献15

  • 1Parkin DM,Whelan SL,Ferlay J,Teppo L,Thomas DB.Cancer Incidence in Five Continents,Vol.VIII IARC Scientific Publications No.155.Lyon:IARC,2002.
  • 2Infection with Helicobacter pylori.IARC monographs on the evaluation of carcinogenic risks to humans.Vol.61.Schistosomes,liver flukes and Helicobacter pylori.Lyon:International Agency for Research on Cancer,1994:177-241.
  • 3Uemura N,Okamoto S,Yamamoto S,Matsumura N,Yamaguchi S,Yamakido M,Taniyama K,Sasaki N,Schlemper RJ.Helicobacter pylori infection and the development of gastric cancer.N Engl J Med 2001; 345:784-789.
  • 4Watanabe T,Tada M,Nagai H,Sasaki S,Nakao M.Helicobacter pylori infection induces gastric cancer in mongolian gerbils.Gastroenterology 1998; 115:642-648.
  • 5Honda S,Fujioka T,Tokieda M,Satoh R,Nishizono A,Nasu M.Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.Cancer Res 1998; 58:4255-4259.
  • 6Hirayama F,Takagi S,Iwao E,Yokoyama Y,Haga K,Hanada S.Development of poorly differentiated adenocar c inoma and car c inoid due to long-t e rm Helicobacter pylori colonization in Mongolian gerbils.J Gastroenterol 1999; 34:450-454.
  • 7Nozaki K,Shimizu N,Ikehara Y,Inoue M,Tsukamoto T,Inada K,Tanaka H,Kumagai T,Kaminishi M,Tatematsu M.Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.Cancer Sci 2003; 94:235-239.
  • 8Take S,Mizuno M,Ishiki K,Nagahara Y,Yoshida T,Yokota K,Oguma K,Okada H,Shiratori Y.The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.Am J Gastroenterol 2005; 100:1037-1042.
  • 9Kamada T,Hata J,Sugiu K,Kusunoki H,Ito M,Tanaka S,Inoue K,Kawamura Y,Chayama K,Haruma K.Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori:results from a 9-year prospective follow-up study in Japan.Aliment Pharmacol Ther 2005; 21:1121-1126.
  • 10Takenaka R,Okada H,Kato J,Makidono C,Hori S,Kawahara Y,Miyoshi M,Yumoto E,Imagawa A,Toyokawa T,Sakaguchi K,Shiratori Y.Helicobacter pylori eradication reduced the incidence of gastric cancer,especially of the intestinal type.Aliment Pharmacol Ther 2007; 25:805-812.

共引文献10

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部